Latest Insider Transactions at Harmony Biosciences Holdings, Inc. (HRMY)
This section provides a real-time view of insider transactions for Harmony Biosciences Holdings, Inc. (HRMY). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Harmony Biosciences Holdings, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Harmony Biosciences Holdings, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 27
2025
|
Sandip Kapadia CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,775
-100.0%
|
$67,450
$38.05 P/Share
|
|
Jan 27
2025
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,629
-100.0%
|
$61,902
$38.02 P/Share
|
|
Jan 24
2025
|
Kumar Budur CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,151
-52.63%
|
$43,738
$38.01 P/Share
|
|
Jan 24
2025
|
Kumar Budur CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,187
+50.0%
|
-
|
|
Jan 24
2025
|
Sandip Kapadia CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,037
-53.44%
|
$77,406
$38.01 P/Share
|
|
Jan 24
2025
|
Sandip Kapadia CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,812
+50.0%
|
-
|
|
Jan 24
2025
|
Jeffrey M. Dayno PRESIDENT, CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,567
-43.5%
|
$173,546
$38.01 P/Share
|
|
Jan 24
2025
|
Jeffrey M. Dayno PRESIDENT, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,500
+50.0%
|
-
|
|
Jan 24
2025
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,058
-39.37%
|
$40,204
$38.01 P/Share
|
|
Jan 24
2025
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
15,812
+50.0%
|
$237,180
$15.35 P/Share
|
|
Jan 24
2025
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
13,125
-80.48%
|
$485,625
$37.4 P/Share
|
|
Jan 24
2025
|
Andrew Serafin CHIEF STRATEGY OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
865
-34.6%
|
$32,870
$38.01 P/Share
|
|
Jan 24
2025
|
Andrew Serafin CHIEF STRATEGY OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+50.0%
|
-
|
|
Jan 21
2025
|
Sandip Kapadia CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
25,000
-100.0%
|
$1,000,000
$40.18 P/Share
|
|
Jan 21
2025
|
Sandip Kapadia CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+50.0%
|
$725,000
$29.03 P/Share
|
|
Jan 21
2025
|
Jeffrey M. Dayno PRESIDENT, CEO |
SELL
Open market or private sale
|
Direct |
19,293
-100.0%
|
$771,720
$40.13 P/Share
|
|
Jan 21
2025
|
Jeffrey M. Dayno PRESIDENT, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
19,293
+50.0%
|
$154,344
$8.22 P/Share
|
|
Jan 21
2025
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,123
-100.0%
|
$44,920
$40.0 P/Share
|
|
Jan 21
2025
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,123
+50.0%
|
$37,059
$33.44 P/Share
|
|
Jan 16
2025
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
29,475
-100.0%
|
$1,090,575
$37.41 P/Share
|
|
Jan 16
2025
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
29,475
+50.0%
|
$972,675
$33.44 P/Share
|
|
Jan 15
2025
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,507
-100.0%
|
$388,759
$37.01 P/Share
|
|
Jan 15
2025
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,507
+50.0%
|
$346,731
$33.44 P/Share
|
|
Jan 13
2025
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,180
-100.0%
|
$265,660
$37.04 P/Share
|
|
Jan 13
2025
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,180
+50.0%
|
$236,940
$33.44 P/Share
|
|
Nov 05
2024
|
Valor Iv Pharma Holdings, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
600,000
-8.31%
|
$18,000,000
$30.3 P/Share
|
|
Nov 05
2024
|
Marshman Fund Trust Ii > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
600,000
-9.02%
|
$18,000,000
$30.3 P/Share
|
|
Nov 01
2024
|
Valor Iv Pharma Holdings, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
4,000,000
-35.66%
|
$120,000,000
$30.3 P/Share
|
|
Nov 01
2024
|
Marshman Fund Trust Ii > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
4,000,000
-37.55%
|
$120,000,000
$30.3 P/Share
|
|
Oct 29
2024
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
21,496
-100.0%
|
$859,840
$40.47 P/Share
|
|
Oct 29
2024
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
21,496
+50.0%
|
$515,904
$24.0 P/Share
|
|
Oct 03
2024
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
36,357
-99.03%
|
$1,272,495
$35.33 P/Share
|
|
Oct 01
2024
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
400
-100.0%
|
$16,000
$40.19 P/Share
|
|
Oct 01
2024
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
400
+50.0%
|
$9,600
$24.0 P/Share
|
|
Sep 30
2024
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
23,643
-39.41%
|
$945,720
$40.0 P/Share
|
|
Sep 30
2024
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
95,846
+50.0%
|
$1,150,152
$12.0 P/Share
|
|
Sep 30
2024
|
Sandip Kapadia CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
32,052
-53.42%
|
$1,282,080
$40.0 P/Share
|
|
Sep 30
2024
|
Sandip Kapadia CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
60,000
+50.0%
|
-
|
|
Sep 30
2024
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
35,846
-100.0%
|
$1,433,840
$40.03 P/Share
|
|
Sep 27
2024
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
200
-100.0%
|
$8,000
$40.05 P/Share
|
|
Sep 27
2024
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
200
+50.0%
|
$4,800
$24.0 P/Share
|
|
Mar 29
2024
|
Sandip Kapadia CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
8,013
-53.42%
|
$264,429
$33.58 P/Share
|
|
Mar 29
2024
|
Sandip Kapadia CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
-
|
|
Mar 15
2024
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
11,979
-100.0%
|
$383,328
$32.0 P/Share
|
|
Mar 15
2024
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
11,979
+50.0%
|
$95,832
$8.22 P/Share
|
|
Mar 08
2024
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
194
-100.0%
|
$6,208
$32.0 P/Share
|
|
Mar 08
2024
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
194
+50.0%
|
$1,552
$8.22 P/Share
|
|
Mar 29
2023
|
Sandip Kapadia CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
15,414
-51.38%
|
$508,662
$33.36 P/Share
|
|
Mar 29
2023
|
Sandip Kapadia CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+50.0%
|
-
|
|
Dec 14
2022
|
Jack Nielsen |
SELL
Open market or private sale
|
Indirect |
2,834
-0.11%
|
$167,206
$59.96 P/Share
|